5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
Phase 1 Recruiting
65 enrolled
Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors
Phase 1 Completed
27 enrolled
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Phase 1 Recruiting
100 enrolled
FdCyd and THU for Advanced Solid Tumors
Phase 1 Completed
59 enrolled
Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors
Phase 1 Completed
50 enrolled
A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy
Phase 1 Completed
17 enrolled
A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas
Phase 1 Completed
55 enrolled
Erlotinib in Combination With Select Tyrosine Kinase Inhibitors in Adult Patients With Advanced Solid Tumors
Phase 1 Withdrawn
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
Phase 1 Completed
29 enrolled
Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer
Phase 1 Completed
58 enrolled 17 charts
Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer
Phase 1 Completed
Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors
Phase 1 Completed
Vaccine Therapy in Treating Patients With Metastatic Cancer
Phase 1 Completed
BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy
Phase 1 Completed
Stereotactic Radiosurgery in Treating Patients With Brain Tumors
Phase 1 Completed
Pazopanib and ARQ 197 for Advanced Solid Tumors
Phase 1 Completed
32 enrolled 21 charts
Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors
Phase 1 Completed
53 enrolled 20 charts
Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)
Phase 1 Completed
38 enrolled 20 charts
Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer
Phase 1 Completed
11 enrolled 18 charts
Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum
Phase 1 Terminated
19 enrolled
Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer
Phase 1 Terminated
39 enrolled
BAY 43-9006 (Sorafenib) and Bevacizumab (Avastin) To Treat Solid Tumors
Phase 1 Completed
57 enrolled
HGS-ETR2 to Treat Children With Solid Tumors
Phase 1 Terminated
30 enrolled
A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid Tumors
Phase 1 Completed
28 enrolled
ABT-888 Plus Metronomic Cyclophosphamide to Treat Cancer
Phase 1 Completed
35 enrolled
AZD7451 for Recurrent Gliomas
Phase 1 Completed
14 enrolled
Depsipeptide to Treat Thyroid and Other Advanced Cancers
Phase 1 Completed
28 enrolled
AZD8055 for Adults With Recurrent Gliomas
Phase 1 Completed
22 enrolled
ZD6474 to Treat Advanced Brain Cancer in Patients
Phase 1 Completed
83 enrolled
Safety of Batracylin in Patients With Solid Tumors and Lymphomas
Phase 1 Completed
33 enrolled
AZD2171 to Treat Children and Adolescents With Solid Tumors or Acute Myelogenous Leukemia
Phase 1 Completed
18 enrolled
Pazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver Function
Phase 1 Completed
8 enrolled
EZN-2208 (Pegylated SN-38) in Combination With Bevacizumab in Refractory Solid Tumors
Phase 1 Completed
12 enrolled
Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy
Phase 1 Completed
34 enrolled
Phase I Trial of Tariquidar (XR9576) in Combination With Doxorubicin, Vinorelbine, or Docetaxel in Pediatric Patients With Solid Tumors
Phase 1 Completed
29 enrolled
Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction
Phase 1 Completed
72 enrolled 23 charts
A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies
Phase 1 Completed
60 enrolled
An Early Phase I Study of IPdR Absorption, Metabolism, and Safety in Patients With Advanced Solid Tumors and Lymphomas
Phase 1 Completed
10 enrolled
Indenoisoquinoline LMP400 for Advanced Solid Tumors and Lymphomas
Phase 1 Completed
21 enrolled
AZD2281 and Cisplatin Plus Gemcitabine to Treat Solid Tumor Cancers
Phase 1 Completed
23 enrolled
A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults With Advanced Solid Tumors With Liver Metastases
Phase 1 Completed
10 enrolled
AT13387 in Adults With Refractory Solid Tumors
Phase 1 Completed
31 enrolled
Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors
Phase 1 Completed
9 enrolled
Adoptive Cell Therapy for B-Cell Cancers in Patients After Stem Cell Transplantation
Phase 1 Completed
11 enrolled
Using Fiducial Markers to Aid in Prostate Cancer Radiation Treatment
Phase 1 Completed
15 enrolled
Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas
Phase 1 Terminated
5 enrolled 15 charts
Cancer Vaccine Targeting Brachyury Protein in Tumors
Phase 1 Completed
34 enrolled 19 charts
Gene Therapy for the Treatment of Brain Tumors
Phase 1 Completed
15 enrolled
Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype
Phase 1 Completed
21 enrolled
Phase I Study of HeFi-1 to Treat Cancers With CD30 Protein
Phase 1 Completed
9 enrolled